Company Filing History:
Years Active: 2017
Title: Mohammed Oukka: Innovator in Immunology
Introduction
Mohammed Oukka is a prominent inventor based in Newcastle, WA (US). He has made significant contributions to the field of immunology, particularly in the modulation and identification of human T17 cells. His innovative work has implications for understanding and treating various immune-related conditions.
Latest Patents
Oukka holds a patent titled "Selective differentiation, identification, and modulation of human TH17 cells." This patent outlines methods for modulating both the differentiation and activity of human T17 cells. Specifically, it describes how TGF-β and IL-21, along with their agonists and antagonists, can influence T17 cell differentiation. Furthermore, the patent details how the function of T17 cells can be modulated by agents such as BLT1 or podoplanin, and their respective agonists and antagonists. The identification of T17 cells is also addressed, highlighting that these cells specifically upregulate BLT1 and podoplanin.
Career Highlights
Oukka is affiliated with Brigham and Women's Hospital, Inc., where he continues to advance research in immunology. His work has garnered attention for its potential to impact therapeutic strategies for autoimmune diseases and other immune disorders.
Collaborations
Oukka has collaborated with notable researchers in the field, including Vijay K Kuchroo and David E Anderson. These collaborations have further enriched his research and contributed to the advancement of knowledge in immunology.
Conclusion
Mohammed Oukka's innovative work in the modulation and identification of human T17 cells represents a significant advancement in immunology. His contributions are paving the way for new therapeutic approaches to immune-related conditions.